Serveur d'exploration SilverBacteriV1

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.

Identifieur interne : 000129 ( Main/Corpus ); précédent : 000128; suivant : 000130

Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.

Auteurs : Eshant Bhatia ; Rinti Banerjee

Source :

RBID : pubmed:32285904

Abstract

Over decades bacteria have evolved multiple mechanisms to fight antibiotics. Biofilm formation by bacteria is one such mechanism as it forms a barrier and creates an acidic environment that reduces the efficiency of antimicrobials. Bacteria have also developed the ability to persist intracellularly within mammalian cells, causing recurrent infections. Many antibiotics are rendered ineffective due to poor penetration across biofilms and within mammalian cells. In this study, silver-gold hybrid nanoparticles were developed as anti-microbial agents to combat biofilm formation and intracellular infections. Biogenic hybrid silver gold nanoparticles were developed in an organic solvent free single reaction mixture using quercetin, a flavonoid, as the reducing and stabilizing agent. Silver-gold nanoparticles of 40 ± 10 nm diameter were effective against a broad spectrum of bacteria with minimum bactericidal concentrations of 10 μg ml-1 and 20 μg ml-1 for Gram negative and Gram-positive organisms, respectively. These nanoparticles were also effective against mixed infections at 20 μg ml-1. Their mode of action involves generating intracellular oxidative stress in both Gram negative and Gram-positive bacteria, which causes damage to the cell wall. Polymicrobial biofilm formation was suppressed and intracellular infection was reduced by 70% to 90% in fibroblast and monocyte cell lines. These results indicate that hybrid silver gold nanoparticles are promising agents to suppress biofilm formation and tackle intracellular infections.

DOI: 10.1039/d0tb00158a
PubMed: 32285904

Links to Exploration step

pubmed:32285904

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.</title>
<author>
<name sortKey="Bhatia, Eshant" sort="Bhatia, Eshant" uniqKey="Bhatia E" first="Eshant" last="Bhatia">Eshant Bhatia</name>
<affiliation>
<nlm:affiliation>Nanomedicine Lab, Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai-400076, India. rinti@iitb.ac.in.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Banerjee, Rinti" sort="Banerjee, Rinti" uniqKey="Banerjee R" first="Rinti" last="Banerjee">Rinti Banerjee</name>
<affiliation>
<nlm:affiliation>Nanomedicine Lab, Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai-400076, India. rinti@iitb.ac.in.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32285904</idno>
<idno type="pmid">32285904</idno>
<idno type="doi">10.1039/d0tb00158a</idno>
<idno type="wicri:Area/Main/Corpus">000129</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000129</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.</title>
<author>
<name sortKey="Bhatia, Eshant" sort="Bhatia, Eshant" uniqKey="Bhatia E" first="Eshant" last="Bhatia">Eshant Bhatia</name>
<affiliation>
<nlm:affiliation>Nanomedicine Lab, Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai-400076, India. rinti@iitb.ac.in.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Banerjee, Rinti" sort="Banerjee, Rinti" uniqKey="Banerjee R" first="Rinti" last="Banerjee">Rinti Banerjee</name>
<affiliation>
<nlm:affiliation>Nanomedicine Lab, Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai-400076, India. rinti@iitb.ac.in.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of materials chemistry. B</title>
<idno type="eISSN">2050-7518</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Over decades bacteria have evolved multiple mechanisms to fight antibiotics. Biofilm formation by bacteria is one such mechanism as it forms a barrier and creates an acidic environment that reduces the efficiency of antimicrobials. Bacteria have also developed the ability to persist intracellularly within mammalian cells, causing recurrent infections. Many antibiotics are rendered ineffective due to poor penetration across biofilms and within mammalian cells. In this study, silver-gold hybrid nanoparticles were developed as anti-microbial agents to combat biofilm formation and intracellular infections. Biogenic hybrid silver gold nanoparticles were developed in an organic solvent free single reaction mixture using quercetin, a flavonoid, as the reducing and stabilizing agent. Silver-gold nanoparticles of 40 ± 10 nm diameter were effective against a broad spectrum of bacteria with minimum bactericidal concentrations of 10 μg ml-1 and 20 μg ml-1 for Gram negative and Gram-positive organisms, respectively. These nanoparticles were also effective against mixed infections at 20 μg ml-1. Their mode of action involves generating intracellular oxidative stress in both Gram negative and Gram-positive bacteria, which causes damage to the cell wall. Polymicrobial biofilm formation was suppressed and intracellular infection was reduced by 70% to 90% in fibroblast and monocyte cell lines. These results indicate that hybrid silver gold nanoparticles are promising agents to suppress biofilm formation and tackle intracellular infections.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">32285904</PMID>
<DateRevised>
<Year>2020</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2050-7518</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>22</Issue>
<PubDate>
<Year>2020</Year>
<Month>06</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>Journal of materials chemistry. B</Title>
<ISOAbbreviation>J Mater Chem B</ISOAbbreviation>
</Journal>
<ArticleTitle>Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.</ArticleTitle>
<Pagination>
<MedlinePgn>4890-4898</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1039/d0tb00158a</ELocationID>
<Abstract>
<AbstractText>Over decades bacteria have evolved multiple mechanisms to fight antibiotics. Biofilm formation by bacteria is one such mechanism as it forms a barrier and creates an acidic environment that reduces the efficiency of antimicrobials. Bacteria have also developed the ability to persist intracellularly within mammalian cells, causing recurrent infections. Many antibiotics are rendered ineffective due to poor penetration across biofilms and within mammalian cells. In this study, silver-gold hybrid nanoparticles were developed as anti-microbial agents to combat biofilm formation and intracellular infections. Biogenic hybrid silver gold nanoparticles were developed in an organic solvent free single reaction mixture using quercetin, a flavonoid, as the reducing and stabilizing agent. Silver-gold nanoparticles of 40 ± 10 nm diameter were effective against a broad spectrum of bacteria with minimum bactericidal concentrations of 10 μg ml-1 and 20 μg ml-1 for Gram negative and Gram-positive organisms, respectively. These nanoparticles were also effective against mixed infections at 20 μg ml-1. Their mode of action involves generating intracellular oxidative stress in both Gram negative and Gram-positive bacteria, which causes damage to the cell wall. Polymicrobial biofilm formation was suppressed and intracellular infection was reduced by 70% to 90% in fibroblast and monocyte cell lines. These results indicate that hybrid silver gold nanoparticles are promising agents to suppress biofilm formation and tackle intracellular infections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bhatia</LastName>
<ForeName>Eshant</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Nanomedicine Lab, Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai-400076, India. rinti@iitb.ac.in.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Banerjee</LastName>
<ForeName>Rinti</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0002-5863-436X</Identifier>
<AffiliationInfo>
<Affiliation>Nanomedicine Lab, Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai-400076, India. rinti@iitb.ac.in.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Mater Chem B</MedlineTA>
<NlmUniqueID>101598493</NlmUniqueID>
<ISSNLinking>2050-750X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32285904</ArticleId>
<ArticleId IdType="doi">10.1039/d0tb00158a</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Terre/explor/SilverBacteriV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000129 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000129 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Terre
   |area=    SilverBacteriV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32285904
   |texte=   Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32285904" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SilverBacteriV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 1 22:59:42 2021. Site generation: Mon Feb 1 23:01:29 2021